Aging, Cognitive Decline, and Dietary Antioxidants
==================================================

Brain aging is a highly complex biological process characterized by a progressive decline of cognitive and physiological abilities. Episodic, working, and spatial memories, as well as processing speed, decline throughout physiological brain aging ([@B29]). Motor and sensory functions are also sensitive to the aging process ([@B77]; [@B40]), and one of the biggest neurobiological challenges in the last decades has been the knowledge of age-associated changes in order to delay cognitive senescence.

Several causal mechanisms of brain aging have been proposed ([@B91]), and one of the most relevant is oxidative stress (OS), caused by an imbalance between generation and detoxification of reactive oxygen species (ROS). The free radical theory of aging postulated by Harman in 1956 points that excessive production and accumulation of ROS causes a subsequent altered cellular integrity that eventually leads to severe and irreversible damage ([@B26]; [@B39]), thus OS plays a crucial role in neuronal damage associated with aging as well as with neurological disorders ([@B84]).

Supplementation with dietary antioxidants can alleviate the redox imbalance. Two important key issues have to be keep in mind regarding the dietary supplementation. The first is the bioavailability (F) of these molecules, their ability to cross membranes and reach the tissues in an appropriated amount to exert their effect. The second aspect is the special characteristics of the biological samples (complex matrix, low volume or weight and trace levels of the targets), which determines that the right choice of the methods of analysis will be essential to ensure a correct interpretation of the results.

The administration of antioxidant molecules extracted from natural sources has been proposed as an alternative form of treatment of age-associated decline in normal brain function ([@B43]; [@B18]; [@B62]), and in this sense vitamins have been used widely as antioxidant therapy. The brain levels of some neurotransmitters have been tested before and after the administration of a single vitamin, and it has been reported that VitD or VitA could have an impact on the levels of some neurotransmitters ([@B56]; [@B57]; [@B25]; [@B42]). However, the most important vitamins regarding their role in the OS reduction and prevention against age-related neurodegeneration are VitC and VitE ([@B64]; [@B79]).

Here, we review the literature that explores the potential of these natural antioxidant vitamins to protect the brain against the aging process. We focus in their effects, the problems and solutions to improve their F, and the most suitable techniques to analyse their levels in biological samples.

Vitamins and Oxidative Stress
=============================

The most powerful water-soluble antioxidant in the organism is VitC, present physiologically as ascorbate anion ([@B68]; [@B27]). Mammals can synthetize VitC in the liver, with the exception of humans, primates or guinea pigs that need to consume it from the diet. In all the cases, ascorbate passes from cerebrospinal fluid to deep brain structures by diffusion, and a sodium-dependent transporter (SVCT2) concentrates ascorbate intracellularly ([@B66]; [@B68]). The most important neuroprotective action of ascorbate is exerted by regulation of extracellular glutamate levels. Excessive glutamate release and accumulation produces neurotoxicity ([@B65]), and the activation of extracellular glutamate uptake involves the release of ascorbate to the extracellular medium by a glutamate-ascorbate heteroexchange membrane transporter ([@B68]). The extracellular concentration of ascorbate in brain tissue is maintained homeostatically at the expense of intracellular stores ([@B66]; [@B63]), and ascorbate may also offer protection at the intracellular compartment ([@B6]).

VitE is the most effective chain-breaking, lipid-soluble antioxidant in cellular membranes ([@B51]), and is one of the major scavengers of radical-oxygenated species in nervous cells ([@B17]). It traps free radicals and breaks the chain reaction, preventing the propagation of lipid peroxidation. This reaction produces a tocopheroxyl radical, which requires ascorbate for its regeneration back to reduced VitE ([@B51]; [@B20]). Thus, the antioxidant effect of VitE is potentiated by co-administration with VitC. In fact, previous studies carried out in animal models ([@B28]) and in humans ([@B37]) reported a more powerful neuroprotective effect when the two vitamins are administered together.

VitE is taken from the diet, incorporated into lipoproteins, and delivered systemically ([@B51]). Such distribution is possible due to the α-tocopherol transfer protein (α-TTP), which controls the hepatic uptake of VitE. α-TTP is present in many organs, including the brain ([@B46]), but its effect on VitE transport remains unclear.

Thus, VitC and VitE are transported into neurons by different carrier proteins, and accumulated by separate systems that act synergically ([@B78]). A recent work ([@B47]) reports the brain distribution of SVCT2 and α-TTP, which display specific patterns that remain unchanged with age. Besides, they are present mainly in neurons but not in astrocytes, and this could contribute to explain the selective responses observed in neurons against OS ([@B85]).

VitC and VitE have been successfully tested in several *in vitro* and in animals models studies in order to improve aging-related process ([@B76]; [@B6]; [@B5]; [@B64]; [@B79]). However, the results obtained from human trials are not always consistent. Low levels of VitC and VitE, as well as other antioxidants, have been observed in plasma of individuals with Alzheimer's disease and mild cognitive impairment ([@B69]; [@B45]), which has led to the suggestion that supplementation with antioxidants could delay or reduce cognitive impairment. The results of the several trials that have already been carried out in the last decades failed to reach a consensus by the role of these vitamins in the treatment of aging and related disease ([@B58]; [@B24]; [@B74]; [@B8]; [@B52]; [@B55]). This can be due, at least in part, to the heterogeneity (e.g., genetic variations as well as differences in diet, lifestyle and environmental factors) of the human population and the difficulty in finding true controls ([@B51]), as well as the inherent variability in amounts of VitE present in regular diets.

Methodological Approaches to Study
==================================

Nanotechnology
--------------

Nanotechnology has contributed to food technology with a wide variety of nanoplatforms such as micelles, micro- nano-emulsions, emulsions or nanoparticles (**Figure [1](#F1){ref-type="fig"}**) ([@B61]; [@B13]; [@B41]; [@B89]). After oral intake, these nanostructures will be able to improve the F of nutraceuticals enhancing their efficacy. Nanoparticles will be able to: (i) avoid the premature degradation of the molecules in physiological fluids; (ii) improve the solubility of the molecules; (iii) promote the diffusion of the cargo across the blanket of mucus that protects the intestinal tract; (iv) facilitate the intra- or para-cellular internalization of the intact form of the bioactive molecule across the intestinal epithelium, and (v) enable their transport through the blood brain barrier ([@B54]; [@B87]; [@B21]; [@B49]).

![Accumulative number of articles (Scopus) and world patents (WIPO) using the keywords "food" and "nanoparticles" up to June 2018.](fnins-12-00721-g001){#F1}

Nanostructures applied in food technology can be classified either as lipid-based or non-lipid-based systems. These nanostructures have been able to improve the F of a wide range of nutraceuticals, such as ω-3/ω-6, PUFAS, polyphenols, vitamins (E, D,...), carotenoids,... ([@B41]; [@B89]). Among others, β-carotene is a clear example of the success of this technology. This antioxidant presents a minimal F, being even lower when the natural extract is ingested without food ([@B22]; [@B67]). However, by encapsulating this molecule in lipid-based nanoparticles its F can be significantly increased ([@B1]). Similarly, encapsulation of curcumin ([@B44]) in liposomes or polyester nanoparticles has reduced the intestinal absorption time ([@B80]; [@B3]). Besides, encapsulation of curcumin significantly improved the F of this polyphenol from 5.3 mg min/L~plasma~ (free curcumin) up to 26.5 mg min/L~plasma~ (encapsulated curcumin). Interestingly, encapsulation did not only increased the plasmatic concentration of curcumin after oral intake, but also preserved better its antioxidant activity along the gastrointestinal tract (GIT) (2.7 folds higher antioxidant activity after oral intake in comparison with the free curcumin) ([@B80]; [@B3]). Irruption of nanotechnology in food technology has implicated the design of nanoparticles using 100% food grade materials, which has challenged the formulation process ([@B73]). Besides, the low added value of food supplements has forced to researchers to the use of low cost formulation process ([@B19]; [@B1]; [@B30]; [@B48]).

From a therapeutic point of view, the principal function of nanostructures in food technology relies on their capacity to improve the F of the encapsulated bioactive molecule, preserving its therapeutic activity from the manufacturing of the supplemented food or beverage up to its delivery in systemic circulation. F of the encapsulated molecule can be expressed as a function of the capacity of the nanostructure to overcome the different biological barriers of the oral route as follows ([@B61]; [@B50]; [@B90]; [@B88]):
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Where F~M~ is the fraction of molecule that is not metabolized along the GIT. As will be discussed in more detail below, the fine tune up of the surface properties of the nanostructure will ensure high F~M~ values along the GIT ([@B60]). F~B~ is the fraction of bioactive molecule bioaccessible, that is, ready to be absorbed through the intestinal cellular wall. Nanostructures can increase the bioaccessibility of the encapsulated molecule through the design different types of nanostructures: mucoadhesive, mucodiffusive or lipid-based digestible. Finally, F~A~ is the fraction of molecule that reach systemic circulation.

Although different manufacturing steps as well as the pass through the GIT does not totally degrade the bioactive molecules, these processes can compromise the activity ([@B80]; [@B3]). Besides, for some bioactive molecules, such as VitE, it is not enough to reach high F values to ensure the desired therapeutic effect. The different isoforms of VitE (α-, β-, γ-, and δ-tocopherols and the corresponding tocotrienols) present different activities, being the most active isoform the RRR- α-T ([@B82]; [@B81]). Therefore, it will be necessary to consider not only the total amount of bioactive molecule that reaches systemic circulation, but also the role of these factors on the overall therapeutic effect (T~E~) of a bioactive molecule:
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Where F represents the overall bioavailability and B~A~ the specific biological activity in plasma. Therefore, to improve the bioavailability or the therapeutic effect of the associated bioactive molecule nanoparticles should be designed in order to enhance F~M~, F~B~, and F~A~. Additionally, the designed nanostructure should preserve as much as possible the biological activity of the associated neuroprotective antioxidant up to reach systemic circulation.

Instrumental Analytical Chemistry
=================================

Despite hybrid analytical techniques result in novel solutions to bioanalytical problems, clinical, medicine or biochemistry fields, are not still used for routine analysis. Hybrid separation techniques are based on couplings between, at least, two instrumental techniques with an appropriate interface, in order to obtain the advantages of the both separation analytical techniques and coupled detector ([@B12]). Different coupling of liquid or gas chromatography (LC or GC) and CE with sensitive and/or selective detector such as spectroscopy (UV-vis, fluorescence, IR..), electrochemical (EC) and MS ([@B70]) are available. Currently, MS has achieved a key role in modern analytical technology due mainly to the online coupling with important separation techniques such as GC (GC-MS), LC (LC-MS/MS), and CE (CE-MS) ([@B72]). The extensive development of the last generation of mass spectrometers coupled to highly efficient LC systems has brought better resolution, sensitivity, and reproducibility in a relatively short time-frame ([@B71]). CE is an important, versatile and rapid technique for the separation of a large number of charged analytes, obtaining high separation efficiency in small sample size and low solvent consumption ([@B72]). The type of sample, target/s compound/s in the determination or required analysis information, in order to select the most suitable hybrid separation technique, should be considered. In this section, a description and discussion about significant and updated analytical methodology developed for the determination of neuroprotectives molecules, mainly VitC and VitE in complex samples is proposed.

Vitamins can be classified into fat-soluble vitamins (FSVs); and water-soluble vitamins (WSVs). Several methods using separation analytical techniques coupling MS, are available to determine FSVs and WSVs compounds in complex matrices ([@B59]; [@B75]). GC-MS is currently used to determinate FSVs and their metabolites, after solvent extraction and derivatization reaction in human serum or plasma ([@B16]). However, High Performance LC with ultraviolet photometric detection (HPLC-UV) ([@B11]) and LC-MS/MS are currently preferred in biological matrices ([@B4]; [@B23]).

VitC is highly instable in biological samples. In that way, Kand'ar et al. ([@B33]) developed a method for the determination of VitC using HPLC-UV to study the stability and recovery into protein precipitation process. Different precipitant agents were tested, and for example, perchloric acid for VitC was unsuitable; however, this HPLC method is a highly sensitive and reproducible for the determination of VitC in human plasma.

Simultaneous determination of L-ascorbic acid using ion-pairing RP-HPLC coupled with EC detector, and other compounds as aminothiols and methionine in biological samples have been presented by [@B34]. Chromatography/ EC method was applied to determinate reduced forms of the analytes in less than 20 min using as the internal standard *n*-acetyl cysteine.

Since L-ascorbic acid is an electro-active molecule, voltammetric techniques, as EC methodology, are selected for the identification and determination of trace concentration in biological samples ([@B10]). A novel voltammetric sensor for determination of VitC based in a moleculary imprinted copolymer has been presented by [@B35]. The molecularly imprinted copolymer sensor exhibited a high sensitivity, selectivity, good reproducibility and stability for the determination of VitC and comparing to conventional polyaniline-based sensors. In the same way, [@B86] developed a simple fluorescence sensor for detection of VitC thanks to the oxidation state change of Au nanoclusters which is controlled by our analyte. The sensor is based in a sensitive turn-off fluorescence a detection limit as low as 0.2 muM applied to biological samples.

Many papers have been published for the simultaneous determination of tocopherols in biological samples ([@B14]). In the same way, chromatography analytical techniques (GC-MS and LC-MS) for the simultaneous determination of tocopherols and tocotrienols in biological and food matrices have been published by [@B7].

Simultaneous determination of VitE and other FSVs and their metabolites in serum of children with cystic fibrosis. They revealed significant changes in the plasma level of the analyzed compounds, VitE among them, presents at extremely low concentrations in patients in comparison to healthy controls ([@B36]).

Simultaneous determination of VitA, VitD, and VitE ([@B2]) and their metabolites have been described using LC-MS/MS in biological samples ([@B31]).

A paper comparing two MS methods using chromatography- MS and LC-MS was published by [@B53] for the quantification of α-T and its oxidation product α-tocopherolquinone (TQ) in human plasma. Method validations were carried out in plasma of male volunteer pre- and post-exercise. Both techniques showed that the ratio of TQ/α-T was elevated by 35% immediately after exercise and had returned to basal levels 24 h later.

In cultured cell lines, tissue, plasma and red blood cells, in human or mouse samples, a single HPLC method has been also developed and validated for determination of all levels using a single protocol of extraction of different types of samples ([@B15]). Other singular sample was used for [@B32] for determination of retinol and α-T using an HPLC with UV detection in human seminal plasma.

Some analytical methods have been developed for determination of the last eight isomers in biological samples ([@B38]). This method was used for carrying out pharmacokinetic studies. Small volume of plasma were extracted with an average recovery of 44.7% and an average matrix effect of -2.9%.

Determination of α and δ-tocopherol (δ-T) in plasma, liver and brain samples after high dietary supplementation was developed by [@B9]. This study provided further information on their *in vivo* functions and pharmacological effects since their pharmacokinetic properties remain poorly characterized. These results show that high dosage α-T and δ-T in mouse and supplementation of sesamin with δ-T further increases δ-T levels over those seen with δ-T supplementation alone.

An ultrafast analytical methodology for determination of α-T in different biopharmaceutical samples using LC-diode array detector on-line ESI--MS/MS has been currently published ([@B83]). The optimized and validated chromatographic method is presented as valuable analytical tool for the determination of α-T in loaded drug delivery systems in blood samples.

Conclusion
==========

In sum, many natural compounds have shown to interact with chemical reactions such as the OS, lipid peroxidation, apoptosis and other mechanisms involved in neuronal damage. In addition, those molecules are able to exert different actions on the neurotransmitter systems. However, nanoplatforms, that improve the F and efficacy of the biomolecules, and correct analytical techniques, are essentials tools in order to obtain the desired results of the treatment to prevent age-related cognitive, motor and sensory impairment.
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